ArticleTheranostics2016

Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas.

Taemoon Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.